|
Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group |
08/26/2025 - 8:45am to 9:30am MDT |
|
Integrated Post-Transplant Monitoring of Pediatric AML by CD34-Sorted Chimerism and Minimal Residual Disease Testing (IMPACT) |
10/14/2025 - 8:45am to 9:30am MDT |
|
Introduction to a Prospective observational trial of NGS MRD for patients with AML who require HSCT |
01/21/2025 - 8:45am to 9:30am MST |
|
Journal Club: Association of GVHD and relapse risk in the PTCy Era |
03/11/2025 - 8:45am to 9:30am MDT |
|
Journal Club: If You Can’t Beat Them, Engineer Them: The Rise of the CD7 CAR-T |
05/06/2025 - 8:45am to 9:30am MDT |
|
Molecular Matchmaking: Pharmacogenomics in HCT |
01/14/2025 - 8:45am to 9:30am MST |
|
Pulmonary Function after Hematopoietic Cell Transplant for Sickle Cell Disease + Fellow Research Presentation |
09/02/2025 - 8:45am to 9:30am MDT |
|
Quality Improvement Projects: Progress & Next Steps |
06/24/2025 - 8:45am to 9:30am MDT |
|
Remestemcel-L-rknd (Ryoncil®) for Steroid-Refractory aGVHD: Novel Therapy at a High Cost |
07/29/2025 - 8:45am to 9:30am MDT |
|
Steroids and the Blood Brain Barrier: Rumor and Reality |
09/30/2025 - 8:45am to 9:30am MDT |